NEW COMPLIANCE PROGRAM GUIDANCE

New compliance program guidance has been issued by the Fraud Section of the Department of Justice (DOJ), according to an article published in the AHLA Weekly. Although the “Evaluation of Corporate Compliance Programs” (Guidance) is not specific to the healthcare industry, it does provide a practical set of benchmarks against which the audit & compliance committee, in consultation with the general counsel and the chief compliance officer, can evaluate the effectiveness of the health system’s compliance program.

New compliance program guidance has been issued by the Fraud Section of the Department of Justice (DOJ), according to an article published in the AHLA Weekly. Although the “Evaluation of Corporate Compliance Programs” (Guidance) is not specific to the healthcare industry, it does provide a practical set of benchmarks against which the audit & compliance committee, in consultation with the general counsel and the chief compliance officer, can evaluate the effectiveness of the health system’s compliance program.

Compliance Guidance based Questions

The Guidance is presented in the form of a series of substantive compliance-focused questions that the Fraud Division frequently considers when evaluating a corporate compliance program, for example:

  • Analysis and Remediation of Underlying Misconduct
  • [Role and Involvement of] Senior and Middle Management
  • Autonomy and Resources
  • Policies and Procedures
  • Risk Assessment
  • Training and Communication
  • Confidential Reporting and Investigation
  • Incentives and Disciplinary Measures
  • Continuous Improvement, Periodic Testing and Review
  • Third Party Management
  • Mergers and Acquisitions

These questions are drawn from multiple sources (e.g., the Federal Sentencing Guidelines and the United States Attorneys Manual, the joint DOJ/SEC Foreign Corrupt Practices Act guide and compliance guidance from the Organization for Economic Cooperation and Development).

Questions particularly relevant to healthcare organizations include those that focus on the conduct of senior and middle management; the internal stature of the compliance function; the autonomy of the compliance function; program funding and resources; corporate response to expressed compliance concerns; the process for responding to investigative findings; consistency of disciplinary measures; and periodic updating of procedures and practices.

Important questions focus on the board’s exercise of its compliance oversight duties—including whether relevant expertise is available on the board and how compliance related information provided to the board.

Lack of Formalized Compliance Programs

As an aside, this guidance underscores the lack of need for formalized compliance programs in small practices consistent with the OIG guidance. Small practices do not have mid or senior level managers or a board in most cases. Small physician practices can, however, take note of some of the key points in their attempts at operating in a compliant fashion. Specifically, how you respond to expressed compliance concerns, investigative findings, and how often you review documentation, coding and billing policies.

One theme that appears to run through the questions is a focus on how the corporation deals with misconduct after it has been identified. This focus goes beyond the traditional emphasis on proper incentives and appropriate discipline to an awareness of the root cause of the misconduct and changes the company made to reduce the potential that similar problems will reappear.

The release of this Guidance is a significant development in terms of assuring the most effective possible corporate compliance plan. It is directly relevant to any organization attempting to demonstrate a commitment to compliance and implementation of an “effective” compliance program. Compliance officers should review and share relevant portions and resulting recommendations with management.

2017 OIG Work Plan: Part B Risk Areas

The Office of Inspector General (OIG) publishes annually a Work Plan describing new, ongoing, and revised areas within the U.S. Department of Health and Human Services (HHS) it will investigate throughout the year for potential fraud, waste, and abuse. It’s wise for providers to review this Work Plan and update their compliance plans accordingly. Here’s a summary of the areas within Medicare Part B on which the OIG plans to focus this year.

Time to give your physician office’s compliance plan an annual preventive exam.

The Office of Inspector General (OIG) publishes annually a Work Plan describing new, ongoing, and revised areas within the U.S. Department of Health and Human Services (HHS) it will investigate throughout the year for potential fraud, waste, and abuse. It’s wise for providers to review this Work Plan and update their compliance plans accordingly. Here’s a summary of the areas within Medicare Part B on which the OIG plans to focus this year.

Durable Medical Equipment (DME) and Supplies

NEW!Part B services during non-Part A nursing home stays – DME: In cases where a beneficiary continues to reside in a skilled nursing facility (SNF) after 100 days (non-Part A stay), Medicare Part B may provide coverage for certain therapy and supplies. A July 2009 OIG study found that Medicare Part B made $30 million in inappropriate DME Prosthetics, Orthotics, and Supplies (DMEPOS) payments. The OIG will evaluate the extent of inappropriate payments under Part B for DMEPOS provided to nursing home residents during non-Part A stays. The OIG also intends to determine if the Centers for Medicare & Medicaid Services (CMS) has a system in place to identify and recoup such overpayments from suppliers.

NEW!Medicare market share of mail-order diabetic testing strips (DTS): The OIG will develop a required report of the market share of DTS prior to each subsequent round of the competitive bidding program.

NEW!Positive airway pressure device supplies – supplier compliance with documentation requirements for frequency and medical necessity: Medicare paid approximately $953 million for continuous positive airway pressure or respiratory assist devices (PAP). Prior OIG analysis found evidence of automatic shipping of PAP supplies when no physician orders for refills were in effect. The importance of compliance cannot be understated. Orders of certificates of medical necessity must specify the type of supplies needed and the frequency of use, replacement, or consumption consistent with the Medicare Program Integrity Manual (publication 100-8, chapter 5, sections 5.2.3, 5.9). Automatic shipment of resupplies is not permitted. The documentation must show a request for resupply by the beneficiary or caregiver before supplies are dispensed, according to the Medicare Claims Processing Manual (publication 100-4, chapter 20, section 200).

Other areas of focus include:

  • Orthotic braces – Reasonableness of Medicare payments compared to amounts paid by other payers
  • Osteogenesis stimulators – Lump-sum purchase versus rental
  • Power mobility devices (PMDs) –  Lump-sum purchase versus rental
  • Competitive bidding for medical equipment items and services – Mandatory review
  • Orthotic braces – Supplier compliance with payment requirements
  • Access to DME in competitive bidding areas
  • Other Providers and Suppliers

NEW!Monitoring Medicare payments for clinical diagnostic laboratory tests: Consistent with the requirements of section 216 of the Protecting Access to Medicare Act (PAMA) of 2014, OIG will analyze the market rates for the top 25 laboratory tests as a means of monitoring CMS’ implementation of the new payment system for these tests.

NEW!Medicare payments for transitional care management: Medicare-covered services, including chronic care management, end-stage renal disease, and prolonged services without direct patient contact cannot be billed during the same service period as transition care management (TCM). OIG will determine whether payments for TCM services were in accordance with Medicare coverage requirements.

NEW!Data brief on financial interests reported under the open payments program: Section 6002 of the Affordable Care Act, sometimes referred to as the Physician Payments Sunshine Act, requires manufacturers to disclose to CMS payments made to physicians and teaching hospitals. OIG intends to analyze the 2015 reporting data to determine the number and nature of financial interests, and will evaluate how much Medicare paid for drugs and DMEPOS ordered by physicians with financial relationships with the supplying entity. The OIG also continues to evaluate the accuracy of the data reported by manufacturers to the open payments system.

NEW!PMD equipment – Portfolio report on Medicare Part B payments: OIG previously identified inappropriate payments for PMDs that were unnecessary, not documented in accordance with Medicare requirements, cheaper to rent than purchase, or fraudulent. OIG will compile results of prior audits, evaluations, and investigations of PMD equipment paid by Medicare to identify trends in payment, compliance, and fraud vulnerabilities. OIG will make recommendations to CMS of any necessary actions.

REVISED!Ambulance services – Supplier compliance with payment requirements: The OIG found that Medicare made inappropriate payments for advanced life support (ALS) services, and based on prior work will determine whether ambulance services including basic life support (BLS), ALS, and specialty care transports were billed in compliance with Medicare requirements.

REVISED!Inpatient rehabilitation facility (IRF) payment system requirements: The OIG will determine whether IRFs nationwide have submitted claims in compliance with Medicare documentation and coverage requirements, based on prior reviews that identified substantial Medicare overpayments to IRFs.

REVISED!Histocompatibility laboratories – supplier compliance with payment requirements: From March 31, 2013, through Sept. 30, 2014, histocompatibility labs reported $131 million in reimbursable costs on their most recent cost reports. Because allowable costs must be related to the care of beneficiaries; be reasonable necessary and proper; and be an allowable cost under the regulations, the OIG will determine whether payments to histocompatibility labs were made in accordance with Medicare requirements.

Other areas the OIG is focusing on (and you should, too):

  • Ambulance services – Questionable billing, medical necessity, and level of transport
  • Payments for Medicare services, supplies, and DMEPOS referred or ordered by physicians – compliance
  • Anesthesia services – Non-covered services
  • Anesthesia services – Payments for personally performed services
  • Physician home visits – Reasonableness of services
  • Prolonged services – Reasonableness of services
  • Chiropractic services – Part B payments for non-covered services
  • Chiropractic services – Portfolio report on Medicare Part B payments
  • Selected independent clinical laboratory billing requirements
  • Physical therapists – High use of outpatient physical therapy services by independent therapists
  • Portable X-ray equipment – Supplier compliance with transportation and setup fee requirements
  • Sleep disorder clinics – High use of sleep testing procedures (CPT® codes 95810 and 95811)
Follow Through

This is a summary of the Part B portion of the 2017 Work Plan; you are encouraged to review the Work Plan in its entirety to ensure applicable risk areas are well understood. For each of your focus areas, be certain to review appropriate CMS interpretive guidance and local coverage determinations, as well as any referenced regulatory provisions cited in the OIG Work Plan to ensure you completely understand and comply with CMS’ expectations, particularly with respect to documentation content and coverage limitations.

Yearly Recovery Statistics

In addition to the 2017 Work Plan, the Office of Inspector General (OIG) separately published its semi-annual report to congress, in which it announced expected recoveries of $5.56 billion from its fraud and abuse efforts in 2016. This amount is up substantially from the $3.3 billion recoveries the OIG projected for 2015. OIG also reported the following statistics relative to its enforcement efforts:

2016 2015 2014
Criminal actions against individuals or entities 844 925 971
Civil actions against individuals or entities 708 682 533
Exclusions 3,635 4,112 4,017

Although criminal action and exclusion figures have fallen, civil actions — which include false claims or unjust enrichment lawsuits, civil monetary penalty settlements, and administrative recoveries relative to provider self-disclosure matters — have risen. The dramatic increase in expected recoveries suggests there is no slowdown in the government’s enforcement efforts, and the importance of compliance cannot be understated.

Source: OIG semi-annual report to Congress

Resources

2016 and 2017 OIG Work Plans: https://oig.hhs.gov/reports-and-publications/workplan/index.asp

Medicare Program Integrity Manual, pub 100-8, ch 5 – Items and Services Having Special DME Review Considerations, §§5.2.3, 5.9.

Medicare Claims Processing Manual, pub 100-4, ch 20 – Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), §200.

HHS ANNOUNCES FRAUD RECOVERY STATISTICS

The American Health Lawyers association reported the following in its weekly Fraud and Abuse update:

The government won or negotiated more than $2.5 billion in healthcare fraud judgments and settlements in fiscal year (FY) 2016, the Departments of Health and Human Services (HHS) and Justice (DOJ) said in their Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2016 released January 19.

The American Health Lawyers association reported the following in its weekly Fraud and Abuse update:

The government won or negotiated more than $2.5 billion in healthcare fraud judgments and settlements in fiscal year (FY) 2016, the Departments of Health and Human Services (HHS) and Justice (DOJ) said in their Health Care Fraud and Abuse Control Program Annual Report for Fiscal Year 2016 released January 19.

“In its twentieth year of operation, the Program’s continued success confirms the soundness of a collaborative approach to identify and prosecute the most egregious instances of health care fraud, to prevent future fraud and abuse, and to protect program beneficiaries,” the agencies said.

According to the report, as a result of 2016 and prior years’ efforts, over $3.3 billion was returned to the federal government or paid to private persons. The Medicare Trust Funds received transfers of approximately $1.7 billion, and $235.2 million in federal Medicaid funds was transferred to the Treasury in FY 2016, the report said.

  • The return on investment from 2014 to 2016 for the Health Care Fraud and Abuse Control Program (HCFAC)—which was established by the Health Insurance Portability and Accountability Act of 1996—is $5 returned for every $1 expended, the agencies said.
  • In FY 2016, DOJ opened 975 new criminal healthcare fraud investigations and filed criminal charges in 480 cases involving 802 defendants. A total of 658 defendants were convicted of healthcare fraud-related crimes during the year, the report said.
  • DOJ opened 930 new civil healthcare fraud investigations in FY 2016, with 1,422 civil health care fraud matters pending at the end of the fiscal year.
  • HHS Office of Inspector General (OIG) investigations resulted in 765 criminal actions in FY 2016 against individuals or entities.

OIG investigations also led to 690 civil actions, which include false claims and unjust-enrichment lawsuits filed in federal district court, civil monetary penalties settlements, and administrative recoveries related to provider self-disclosure matters, according to the report. OIG also excluded 3,635 individuals and entities in FY 2016.

BILLERS CONVICTED IN FRAUD SCHEMES

U.S. Attorney for the District of Maryland, Rod J. Rosenstein announced December 20 that Elma Myles pled guilty to defrauding Medicaid and other health benefit programs by conspiring to have durable medical equipment provider RX Resources and Solutions (RXRS) bill for supplies that were never provided or were medically unnecessary, and to overcharge for materials that were actually delivered.

Myles, who worked for RXRS as a biller, admitted to conspiring with the company’s President and Chief Executive Officer, co-defendant Harry Crawford, and others in connection with the scheme, a press release said. An analysis of RXRS billing revealed that from 2007 through 2014, Medicaid lost roughly $1.2 million just for incontinence supplies, the release said.

U.S. Attorney for the District of Maryland, Rod J. Rosenstein announced December 20 that Elma Myles pled guilty to defrauding Medicaid and other health benefit programs by conspiring to have durable medical equipment provider RX Resources and Solutions (RXRS) bill for supplies that were never provided or were medically unnecessary, and to overcharge for materials that were actually delivered.

Myles, who worked for RXRS as a biller, admitted to conspiring with the company’s President and Chief Executive Officer, co-defendant Harry Crawford, and others in connection with the scheme, a press release said. An analysis of RXRS billing revealed that from 2007 through 2014, Medicaid lost roughly $1.2 million just for incontinence supplies, the release said.

Raciel Leon, 42, of Miami, was convicted after a two-week jury trial of one count of conspiracy to commit health care fraud and wire fraud and one count of conspiracy to defraud the United States and pay and receive health care bribes and kickbacks.

According to evidence presented at trial, between approximately October 2014 and June 2015, Leon was the manager of Mercy Home Care Inc. (Mercy) and a billing employee for D&D&D Home Health Care Inc. (DDD), both of which were home health agencies in Miami-Dade County, Florida. The evidence showed that Leon and his co-conspirators used the companies to submit false claims to Medicare that were based on services that were not medically necessary, not actually provided and for patients that were procured through the payment of illegal kickbacks to doctors and patient recruiters. In an attempt to support the false claims, Leon’s co-conspirators forged prescriptions and other medical records, and Leon submitted claims to Medicare based on the falsified documentation.

As is evident, fraud liability attached to the billers in these cases because of their ACTIVE INVOLMENT as decision-makers and conspirators in the scheme to defraud.

IS SEPARATE CODING OF SERVICES UNBUNDLING OR CORRECT CODING?

If appropriate rules and system edits are in place, exclusionary modifiers are the link to unbundling liability.

Unbundling is a commonly asserted but often misunderstood fraud theory, even by coding experts. When evaluating potential unbundling as a fraud theory, it’s important to differentiate when separate reporting of services is simply correct coding and when it becomes a scheme to defraud.

The Office of Inspector General (OIG) has defined unbundling as occurring when a “billing entity uses separate billing codes for services that have an aggregate billing code” (65 F.R. No. 243, 70138, 70142).

If appropriate rules and system edits are in place, exclusionary modifiers are the link to unbundling liability.

Unbundling is a commonly asserted but often misunderstood fraud theory, even by coding experts. When evaluating potential unbundling as a fraud theory, it’s important to differentiate when separate reporting of services is simply correct coding and when it becomes a scheme to defraud.

The Office of Inspector General (OIG) has defined unbundling as occurring when a “billing entity uses separate billing codes for services that have an aggregate billing code” (65 F.R. No. 243, 70138, 70142). The OIG has also defined unbundling as “billing for eachcomponent of the service instead of billing or using an all-inclusive code” (65 F.R. No. 194, 59434, 59439). Unfortunately, these definitions are too simplistic. Knowing when unbundling is potentially problematic requires an understanding of the differences between the rules pertaining to coding, billing, and reimbursement.

First Comes Coding

“Medical coding,” according to AAPC, “is the transformation of healthcare diagnosis, procedures, medical services, and equipment into universal medical alphanumeric codes.” CPT® and HCPCS Level II codes are the required code set for reporting physician services and supplies to Medicare (45 C.F.R. §162.1002). Each aspect of a physician encounter that can be described using either a CPT® or HCPCS Level II code can, and should, be coded, so all physician work performed can be understood.

Next Comes Billing

Medical billing is the work necessary to translate a properly coded healthcare service into a claim. It is the process by which services are reported to either the patient or to a third-party payer for payment either on a CMS-1500 claim form or electronically using the 5010-transaction standard.

The responsibility of a medical biller in a healthcare facility is to follow the claims to ensure the practice receives appropriate reimbursement for the work the providers perform. A knowledgeable biller can optimize revenue performance for the practice.

Billing a service should not be confused with whether a service is “billable,” which suggests analyzing whether a service is reimbursable. Semantics aside, all services that are performed and correctly coded are billable. Whether a provider or entity chooses to report or “bill” a particular service in circumstances where they don’t think the service is compensable often depends on the objectives of the provider or entity. When the objective is an efficient claims process, the provider or entity may elect not to bill a non-compensable service. Alternatively, when the objective is to classify completely the work performed, or it’s mandated by the payer, the provider or entity includes the CPT® or HCPCS Level II codes associated with the non-compensable components of the service on the claim (bill). In some cases, this is done just to demonstrate to the patient that the service is, in fact, not covered so the patient can understand their payment obligation.

Then Comes Reimbursement, Maybe

In third-party payer cases, such as Medicare, before a coverage and reimbursement determination is made, the physician must:

  • Perform a service(s) on behalf of a patient;
  • Identify and assign the appropriate CPT® and/or HCPCS Level II code(s) to completely represent each component of the overall service provided; and
  • Report that information (as well as other necessary information) to the payer through submission of a claim.

The payer evaluates the claim and makes a coverage determination based on the terms of the patient’s benefit contract or the cost containment provisions of the statutory reimbursement scheme found under programs like Medicare, Medicaid, workers’ compensation, or automobile first-party benefit programs. For covered services, the payer makes a payment determination based on the applicable fee schedule and other reimbursement rules.

Because coverage and reimbursement rules vary from payer to payer (and even plan to plan), the ultimate payment result can vary for the exact same service(s) among payers and plans. It is these “other reimbursement rules” where the concept of unbundling becomes a potential issue.

Unbundling Scenario

In this scenario, a provider is submitting claims to an automobile carrier. Medicare reimbursement rules are applicable and the provider is not permitted under the reimbursement regulations to “fragment or unbundle claims except as consistent with Medicare.” The provider performs decompressive neuroplasty, which involves:

  • An injection of lidocaine (62311 Injection(s), of diagnostic or therapeutic substance(s) (including anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, includes contrast for localization when performed, epidural or subarachnoid; lumbar or sacral (caudal));
  • A myelogram without dural puncture of the L5 nerve root with contrast, which necessarily involves the injection procedure for myelography (62284 Injection procedure for myelography and/or computed tomography, spinal (other than C1-C2 and posterior fossa)) and the actual myelogram (72265 Myelography, lumbosacral, radiological supervision and interpretation);
  • A percutaneous neuroplasty involving the injection of saline (62282 Injection/infusion of neurolytic substance (eg, alcohol, phenol, iced saline solutions), with or without other therapeutic substance; epidural, lumbar, sacral (caudal)); and
  • Fluoroscopic guidance for each of the various procedures (77003 Fluoroscopic guidance and localization of needle or catheter tip for spine or paraspinous diagnostic or therapeutic injection procedures (epidural or subarachnoid)).

Because Medicare reimbursement rules are applicable, Medicare’s fee schedule is relevant, as are National Correct Coding Initiative (NCCI) edits. In analyzing the NCCI edits relative to all of the above codes, only the myelogram (72265) is payable. The other procedures, either directly or indirectly, are considered components of the myelogram.

In this circumstance, is it improper for a provider to separately report each service — and if he or she did, does it constitute impermissible unbundling?

To answer this, first understand that NCCI is a reimbursement rule. For services reported to Medicare, the Medicare administrative contractor (MAC) would apply the NCCI edits and deny payment for all services except the myelogram (72265). Separate reporting of bundled services is not impermissible unbundling when separate reporting was not intended to, and does not reasonably lead to, improper reimbursement. In this scenario, separate reporting was simply the correct and complete reporting of the entire service. Such reporting methods are performed for cost tracking, provider compensation tracking (where providers are in part compensated based on worked relative value units (RVUs)), or other reasons. In fact, Medicare Outpatient Prospective Payment System rules require separate reporting of each service and supply provided in an outpatient hospital or ambulatory surgical center (ASC) so Medicare can track outlier and transitional corridor payments.

According to the Medicare Claims Processing Manual, Pub. 100-4, Chapter 4, Section 10.4: “[I]t is extremely important that hospitals [and ASCs] report all HCPCS codes consistent with their descriptors; CPT and/or CMS instructions and correct coding principles, and all charges for all services they furnish, whether payment for the services is made separately paid [sic] or is packaged.”

When Separate Reporting Becomes Unbundling and Potentially Fraudulent

Separately reporting services using exclusionary modifiers to bypass the automatic bundling of the payment is problematic. The potential fraud theory is not in separately reporting the various procedures, but in the misrepresentation associated with reporting the modifier. Modifiers in these situations make a more important representation regarding the payer’s reimbursement obligation than the procedure code. For potential fraud liability to exist, the misrepresentation must be “material” and “knowing.”

A material misrepresentation impacts the payer’s obligation to pay the claim at all, or the amount of payment that the payer is obligated to make. When a modifier, such as modifier 59 Distinct procedural service, is used without justification and results in an unentitled payment, the separate reporting becomes unbundling, which is actionable.

Heed Relevant Reimbursement Rules

Although NCCI bundling rules are used in the above scenario, don’t assume NCCI is always a relevant reimbursement rule. CPT® Editorial Panel code guidance has its own set of bundling rules relative to what services are included or excluded. As these instructions are beyond the scope of the national standard code set, it’s important to determine whether such instructions are relevant.

The terms of cost containment regulations pertaining to automobile first-party or workers’ compensation claims vary from state to state. They may incorporate NCCI or CPT® Editorial Panel guidance relative to reimbursement. In a worst-case scenario, both are incorporated, leading to the likelihood of conflict between the rules.

For commercial indemnity insurers, the same problems can exist. In many cases, there are no reimbursement rules pertaining to bundling. In others, the carrier may incorporate NCCI, CPT® Editorial Panel guidance, or its own bundling rules. It does so either expressly in the provider agreement or indirectly through incorporated medical or reimbursement policies. As a result, you must identify that a relevant and binding reimbursement rule supports your unbundling theory. Even when such rules are identified, you must delineate whether the provider simply reported the services performed, or inappropriately unbundled services. If exclusionary modifiers are not used, without an expressed and binding instruction to not report certain services separately, unbundling as a fraud theory is a difficult case to make.

Accurate Coding Is Never Fraud

Although inappropriate unbundling can result in significant overpayments, many unbundling cases are defeated because the provider simply reported each service that was done using accurate CPT® and/or HCPCS Level II codes. When services are separately reported without instruction to the contrary, and without additional modifiers (which cause separate payment where it may not be entitled), such reporting simply notifies the payer of all the procedures for the entire service. It’s up to the payer to then determine what components of the service are compensable under the applicable reimbursement rules. The absence of such rules precludes the viability of unbundling as a fraud theory. If there are appropriate rules and system edits in place, and a provider misuses exclusionary modifiers to bypass those payment edits to receive unentitled reimbursement, then an allegation of unbundling by the provider as a fraud theory is potentially sustainable.

Resources

OIG Compliance Guidance for Third Party Medical Billing Companies, 65 F.R. No. 243, 70138, 70142 (Dec. 18, 1998): https://oig.hhs.gov/fraud/docs/complianceguidance/thirdparty.pdf

OIG Compliance Guidance for Individual and Small Group Practices, 65 F.R. No. 194, 59434, 59439 (Oct. 5, 2000): https://oig.hhs.gov/authorities/docs/physician.pdf

AAPC, What Is Medical Coding?

AAPC, What Is Medical Billing?

Medicare Claims Processing Manual, IOM Pub. 100-4, Ch. 4, §10.4